Dahlia Bio

Private

Cambridge-based biotech engineering AI-designed antibody-drug conjugates for pediatric leukemia.

Founders Priya Sharma

CEO Priya Sharma

Company

Founded

2022

Headquarters

Cambridge, United States

Financials

Total Funding

$154M

Sectors

Biotech

dahliabio.com

Funding History

3 rounds

Series B Aug 3, 2026

$92M

Flagship Pioneering (Lead) ARCH Venture Partners Third Rock Ventures

Series A Aug 25, 2024

$48M

Third Rock Ventures (Lead) ARCH Venture Partners Flagship Pioneering

Seed Feb 20, 2023

$14M

Third Rock Ventures (Lead) ARCH Venture Partners

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.